PACB - Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line revenue of $35.5M beats by $0.34M August, 03 2022 05:20 PM Pacific Biosciences of California Inc. Pacific Biosciences of California press release ( NASDAQ: PACB ): Q2 Non-GAAP EPS of -$0.34 in-line. Revenue of $35.5M (+16.0% Y/Y) beats by $0.34M . For further details see: Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M